https://scholars.lib.ntu.edu.tw/handle/123456789/511644
標題: | Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB | 作者: | JUNG-YIEN CHIEN Chen Y.-T. CHIN-CHUNG SHU Lee J.-J. JANN-YUAN WANG CHONG-JEN YU PAN-CHYR YANG |
公開日期: | 2013 | 出版社: | American College of Chest Physicians | 卷: | 143 | 期: | 6 | 起(迄)頁: | 1725-1732 | 來源出版物: | Chest | 摘要: | Background: Sputum samples from patients with non-multidrug-resistant (non-MDR) pulmonary TB may remain smear-positive for acid-fast bacilli (AFB) at the fifth month of anti-TB treatment. However, its significance remains unknown. Methods: From January 2004 to April 2009, there were 5,403 patients with culture-confirmed pulmonary TB from four hospitals in Taiwan. Among them, 116 patients (2.2%) with non-MDR TB whose sputum samples were smear-positive by concentration smear method at the fifth month of treatment were evaluated. Results: Sputum culture yielded Mycobacterium tuberculosis in 10 patients (8.6%, MTB group), nontuberculous mycobacteria in 23 (19.8%, NTM group), and no growth in the remaining 83 (71.6%, no-growth group). The relapse rate (22%) was higher in the MTB group (P=.01). Four predictors, smear grading ? 3+ at the fifth month ("S") (OR, 10.73; 95% CI, 2.67-43.17), no sputum culture conversion on the second month ("C") (OR, 7.16; 95% CI, 1.45-35.44), lack of directly observed therapy ("O") (OR, 6.40; 95% CI, 1.54-26.56), and no radiographic improvement at the fifth month ("R") (OR, 4.18; 95% CI, 1.02-17.10), were associated with viable M tuberculosis (MTB group). An integrated "SCOR" index of 1 point for each positive factor had the best discriminatory power for predicting culture results at the fifth month. If the SCOR index was 0, all smear-positive sputum was culture-negative for M tuberculosis. Conclusions: Positive sputum smears by a concentrated smear method at the fifth month of treatment in patients with non-MDR TB, especially those with a low SCOR index, may be due to nonviable bacilli and NTM. Careful review of the quality of patient supervision, bacteriologic data, and chest radiography is crucial. ? 2013 American College of Chest Physicians. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878595292&doi=10.1378%2fchest.12-2051&partnerID=40&md5=6c733d5f89a28732b3b7b3f5877cfdb4 https://scholars.lib.ntu.edu.tw/handle/123456789/511644 |
ISSN: | 0012-3692 | DOI: | 10.1378/chest.12-2051 | SDG/關鍵字: | ethambutol; isoniazid; pyrazinamide; rifampicin; adult; aged; article; bacterium detection; clinical evaluation; controlled study; female; human; lung tuberculosis; major clinical study; male; multidrug resistance; multidrug resistant tuberculosis; Mycobacterium tuberculosis; non multidrug resistant tuberculosis; predictive value; prevalence; priority journal; receiver operating characteristic; relapse; sensitivity and specificity; sputum culture; sputum smear; Taiwan; treatment duration |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。